Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumours

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
T AparicioP Rougier

Abstract

A few studies have suggested an antitumour activity of somatostatin analogues in neuroendocrine tumours (NET). The aim of this study was to evaluate the antitumour efficacy of somatostatin analogues in patients with documented progressive tumours. 35 consecutive patients with documented tumour progression were treated with somatostatin analogues. Patients were classified into two groups. In Group 1, tumours were progressing rapidly (an increase of 50% or more in the lesion surface area in 3 months) and in Group 2, tumours were progressing more slowly (an increase of less than 50% in the lesion surface area in 3 months but greater than 25% in 6 months). Treatment consisted of subcutaneous (s.c.) octreotide, 100 microg thrice daily for 17 patients, intramuscular lanreotide, 30 mg/every 14 days for 11 patients and for 7 patients both somatostatin analogues were used successively during the follow-up. Primary tumour sites were the small intestine (n=12), pancreas (n=13), lungs (n=5), and other sites (n=5). 18 patients had the carcinoid syndrome with flushing and/or diarrhoea. The median duration of treatment was 7 months. Treatment was discontinued in 3 patients due to side-effects. One patient (3%) achieved a partial response and ...Continue Reading

References

Aug 1, 1986·World Journal of Surgery·M MignonS Bonfils
Jan 1, 1995·Virchows Archiv : an International Journal of Pathology·C CapellaG Klöppel

❮ Previous
Next ❯

Citations

Mar 4, 2011·Cancer Metastasis Reviews·Michael D CullerJosé Angel Díaz
Jan 22, 2009·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·A Pinto MarínM González Barón
Sep 3, 2013·Annales d'endocrinologie·Eric BaudinUNKNOWN Groupe d’étude des tumeurs endocrines
Apr 14, 2004·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·F PanzutoG Delle Fave
Apr 14, 2004·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·F Gibril, R T Jensen
Mar 23, 2010·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Aldo ScarpaMassimo Falconi
Jun 3, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T R HalfdanarsonG M Petersen
May 13, 2005·Gut·J K RamageUNKNOWN UKNETwork for Neuroendocrine Tumours
Nov 5, 2011·Gut·John K RamageUNKNOWN UK and Ireland Neuroendocrine Tumour Society
Apr 21, 2012·International Journal of Hepatology·Ron BasuroyJohn K Ramage
Feb 22, 2007·Neuroendocrinology·Dermot O'TooleUNKNOWN European Neuroendocrine Tumor Society
Feb 22, 2007·Neuroendocrinology·Massimo FalconiUNKNOWN European Neuroendocrine Tumor Society
Nov 6, 2009·Journal of Experimental & Clinical Cancer Research : CR·Maximilian Schöniger-HekeleChristian Müller
Mar 4, 2010·Journal of Experimental & Clinical Cancer Research : CR·Marialuisa Appetecchia, Roberto Baldelli
May 26, 2012·The Oncologist·Lucas SidérisAnja Rinke
Apr 10, 2010·World Journal of Gastroenterology : WJG·Gilles PoncetThomas Walter
Jun 24, 2010·World Journal of Gastroenterology : WJG·Jonathan Strosberg, Larry Kvols
Jan 11, 2014·Trends in Endocrinology and Metabolism : TEM·Mounira ChalabiCorinne Bousquet
Feb 18, 2014·Brain Tumor Pathology·K MatsudaT Kayama
Jan 2, 2008·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Anu DhamArkadiusz Z Dudek
Sep 16, 2015·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Diego Marquez-Medina, Sanjay Popat
Jul 23, 2013·Frontiers in Neuroendocrinology·Marily Theodoropoulou, Günter K Stalla
Aug 5, 2011·Clinical Colorectal Cancer·Sameer GuptaSteven J Cohen
Sep 13, 2011·Clinical Oncology : a Journal of the Royal College of Radiologists·K E Oberg
Feb 26, 2011·Endocrinology and Metabolism Clinics of North America·Guillaume NicolasFlavio Forrer
Aug 7, 2009·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·S L OngA R Dennison
Mar 3, 2009·Critical Reviews in Oncology/hematology·Gabriele CapursoGianfranco Delle Fave
Oct 24, 2008·Gastroentérologie Clinique Et Biologique·J-M Kanyinda-KM Ychou
Mar 21, 2008·Gastroentérologie Clinique Et Biologique·Gaëlle MontmayeurXavier Durando
Mar 25, 2008·Molecular and Cellular Endocrinology·Stéphane PyronnetChristiane Susini
Aug 3, 2006·Surgical Oncology Clinics of North America·Rebecca S Sippel, Herbert Chen
Apr 25, 2006·Endocrinology and Metabolism Clinics of North America·Peter SimonHenri Wallaschofski
Mar 3, 2007·The Journal of Pharmacy and Pharmacology·Hank S WangJoseph R Pisegna
Apr 25, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Irvin M ModlinGeeta Eick
Sep 27, 2005·Best Practice & Research. Clinical Gastroenterology·U Plöckinger, B Wiedenmann
Sep 27, 2005·Best Practice & Research. Clinical Gastroenterology·Tahir Shah, Martyn Caplin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.